financetom
Business
financetom
/
Business
/
Performance Food Fiscal Q3 Adjusted Earnings Fall, Sales Rise; Fiscal 2025 Revenue Outlook Revised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Performance Food Fiscal Q3 Adjusted Earnings Fall, Sales Rise; Fiscal 2025 Revenue Outlook Revised
May 26, 2025 2:40 AM

07:36 AM EDT, 05/07/2025 (MT Newswires) -- Performance Food Group ( PFGC ) reported fiscal Q3 adjusted earnings Wednesday of $0.79 per diluted share, down from $0.80 a year earlier.

Analysts polled by FactSet expected $0.87.

Net sales for the quarter ended March 29 were $15.31 billion compared with $13.86 billion a year earlier.

Analysts surveyed by FactSet expected $15.32 billion.

For fiscal 2025, the company said it now expects net sales of $63 billion to $63.5 billion, compared with its prior range of $63 billion to $64 billion. Analysts surveyed by FactSet expect $62.95 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lennox International to Acquire HVAC Division of NSI Industries for $550 Million
Lennox International to Acquire HVAC Division of NSI Industries for $550 Million
Aug 18, 2025
08:32 AM EDT, 08/18/2025 (MT Newswires) -- Lennox International ( LII ) said Monday it has agreed to acquire the HVAC division of NSI Industries from Sentinel Capital Partners for $550 million. The acquisition includes well-known brands such as Duro Dyne and Supco, which produce essential HVAC components and technician-focused parts, the company said. The deal, expected to close in...
Opus Genetics Says FDA Approved Investigational New Drug Application for Retinal Diseases Drug Candidate
Opus Genetics Says FDA Approved Investigational New Drug Application for Retinal Diseases Drug Candidate
Aug 18, 2025
08:28 AM EDT, 08/18/2025 (MT Newswires) -- Opus Genetics ( IRD ) said Monday that the Investigational New Drug application for its OPGx-BEST1 gene therapy to treat bestrophin-1-related inherited retinal diseases was approved by the US Food and Drug Administration Following the approval, the company said it intends to start a phase 1/2 clinical trial in H2 2025 to evaluate...
LakeShore Biopharma Gets Buyout Bid From Oceanpine Capital; Shares Up Pre-Bell
LakeShore Biopharma Gets Buyout Bid From Oceanpine Capital; Shares Up Pre-Bell
Aug 18, 2025
08:32 AM EDT, 08/18/2025 (MT Newswires) -- LakeShore Biopharma ( LSB ) shares were up nearly 8% in recent Monday premarket activity after the company said it had received a preliminary non-binding proposal letter from Oceanpine Capital to acquire the biopharmaceutical company in an all-cash deal. The deal value of $0.86 per share represents a 10.3% premium to LakeShore's close...
Tesla says Model Y L 'coming soon' in Chinese social media post
Tesla says Model Y L 'coming soon' in Chinese social media post
Aug 18, 2025
BEIJING, Aug 18 (Reuters) - Tesla said in a post on the Chinese social media platform Weibo on Monday that its Model Y L was coming soon, having previously registered plans to introduce the new six-seater electric vehicle in China. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved